Thus we analyzed coculture of p53-positive and -deficient HCT116 cells - an in vitro model of tumor heterogeneity - to determine whether liquid plasma can have anticancer effects on cocultured differing cancer cells (Fig. 3A). This evidence concerns the gene TP53 and cancer.